Ligand Pharmaceuticals Incorporated
$5.33B- Market cap
- $5.69B
- Debt
- +$374.08M
- Cash
- −$733.52M
Capital structure 94% equity / 6% debt · EV / Revenue 19.90x · EV / EBITDA 33.29x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
LGND · current priceP/E 46.60x
$285.64Latest market snapshot
Implied fair value · at MCHP's multiple
$2,067.20623.7% above market
6.13 LGND EPS (TTM)×337.23x MCHP P/E=$2,067.20
Market $285.64Implied $2,067.20
MCHP · current priceP/E 337.23x
$74.19Latest market snapshot
Implied fair value · at LGND's multiple
$10.2586.2% below market
0.22 MCHP EPS (TTM)×46.60x LGND P/E=$10.25
Market $74.19Implied $10.25